We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Cryptococcal meningitis caused an estimated 15% of ...

This double-blind trial enrolled adults with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All patients received combination antifungal therapy of ...

Background. Cryptococcal meningitis (CM) in South Africa is often treated with fluconazole as initial therapy. Surveillance data suggest that the prevalence of fluconazole-resistant CM is increasing, ...

-The PLATFORM-CM trial is evaluating oteseconazole and other investigational products against the standard of care for treating cryptococcal meningitis "We are excited to initiate this important study ...

Background. Individuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection to cryptococcal ...

A research project studying how best to implement "back to basics" clinical and laboratory care in public hospitals in three African countries has halved the number of deaths from HIV-linked ...

Nelesh P. Govender currently receives funding from the National Institutes of Health and US Centers for Disease Control and Prevention. South Africa has launched the world’s largest national screening ...

Cryptococcal meningitis, the second-leading cause of HIV-related deaths, is expected to rise as access to care weakens and advanced HIV disease (previously called AIDS) increases. A new, ...

SSUCv3H4sIAAAAAAAEAIVSy27DIBC8V+o/WJxj1WDHxf2CXvoFUQ8YNjaKYyIMqarI/971g5SmUnJjZ2eH2cfl+SlJSC0GLclbcpkijHXX ...

As a result of a large randomized, controlled trial (and experience during the first 15 years of the AIDS epidemic), standard guidelines for treatment of cryptococcal meningitis recommend 2 weeks of ...

A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II clinical trials in Malawi and ...

Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...